[Inhalation and peroral mucolytic therapy in mucoviscidosis in children].

Abstract

The paper summarizes the results of clinical studies of 98 children with mucoviscidosis whose age was 7 to 18 years. There is research evidence for possibility and expediency of using new classes of mucolytic agents in the therapy of mucoviscidosis in children. Analysis of the rheological properties of sputum showed the advantage of inhalation route of… (More)

Topics

Cite this paper

@article{Uglitskikh1996InhalationAP, title={[Inhalation and peroral mucolytic therapy in mucoviscidosis in children].}, author={A K Uglitskikh and M Anwar H Khan and Sergei Sharapov and Nikolai I Kapranov and L F Plisko}, journal={Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury}, year={1996}, volume={5}, pages={15-8} }